Homrich & Berg raised its position in shares of UnitedHealth Group (NYSE:UNH) by 24.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,211 shares of the healthcare conglomerate’s stock after acquiring an additional 1,414 shares during the period. Homrich & Berg’s holdings in UnitedHealth Group were worth $1,590,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Exane Derivatives raised its position in shares of UnitedHealth Group by 15,333.3% during the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after buying an additional 460 shares during the last quarter. Intellectus Partners LLC raised its position in shares of UnitedHealth Group by 18.2% during the second quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after buying an additional 126 shares during the last quarter. Wealthcare Advisory Partners LLC raised its position in shares of UnitedHealth Group by 461.9% during the third quarter. Wealthcare Advisory Partners LLC now owns 826 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 679 shares during the last quarter. NuWave Investment Management LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $168,000. Finally, Legacy Advisors LLC raised its position in shares of UnitedHealth Group by 546.0% during the fourth quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock valued at $176,000 after buying an additional 677 shares during the last quarter. Institutional investors own 86.79% of the company’s stock.
A number of research analysts have recently commented on UNH shares. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price objective for the company in a research report on Tuesday. Deutsche Bank upped their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 16th. BMO Capital Markets upped their price objective on shares of UnitedHealth Group from $14.50 to $275.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Credit Suisse Group increased their price target on shares of UnitedHealth Group from $252.00 to $260.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $244.06.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $2.11 earnings per share. equities analysts predict that UnitedHealth Group will post 12.51 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s payout ratio is 29.79%.
In other news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares of the company’s stock, valued at $434,302,025.85. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Larry C. Renfro sold 22,184 shares of the firm’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the sale, the insider now directly owns 173,229 shares of the company’s stock, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 77,015 shares of company stock valued at $17,879,199. Company insiders own 0.89% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3334223/unitedhealth-group-unh-holdings-raised-by-homrich-berg.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.